Lightning Round: Greatest spec of the year

It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:

GW Pharmaceuticals: "The stock is up too much. Let it come in, but I do believe that if they can get this epilepsy drug to also in another version go for just pain killing, it will wipe out Oxycodone and we will be able to buy it."

Jazz Pharmaceuticals: "We have decided to stay away from the really speculative biotech stocks. I can not recommend that right now."

Skechers: "I think Skechers will be 3 or 4 down on the next quarter, and then start going up. The long term you've got to take a position and like it."

Read more from Mad Money with Jim Cramer

Cramer Remix: My rules on how to play Valeant
Cramer: You could have avoided Valeant's disaster
Well-paid employees & cheap food: MOD Pizza

Intrexon: "Intrexon I regard as one of the great specs of the year. There are many things that could happen. It could get crushed! But it also could be up big. You have to swing for the fences if you do Intrexon."

KKR & Co: "They had to slash the dividend because they don't have any equity markets to be able to bring a lot of companies out. But I'm not backing away. I think these are smart guys. Smart guys, it's been a terrible stock. Smart guys, though."

Ashland: "I happen to like the fundamentals. Bruce Kamich who does the chart work at RealMoney.com said the charts aren't ready yet. I think the fundamentals are ready and I like Ashland."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com